AngioDynamics
ANGO
146 hedge funds and large institutions have $374M invested in AngioDynamics in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 60 increasing their positions, 52 reducing their positions, and 23 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 52
8% less funds holding
Funds holding: 158 → 146 (-12)
13.19% less ownership
Funds ownership: 110.82% → 97.63% (-13%)
14% less capital invested
Capital invested by funds: $435M → $374M (-$61M)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
66% less call options, than puts
Call options by funds: $113K | Put options by funds: $332K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.64M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$2.79M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.61M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$2.43M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$49.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.3M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$3.61M |
| 4 |
Goldman Sachs
New York
|
-$2.26M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.67M |
ANGO Hedge Fund Activity: Q2 2020 in Review
146 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2020, worth a combined $374M — down 14% from $435M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ANGO and 11 opened new positions — a net loss of 12 holders — while 52 trimmed existing stakes and 60 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $3.64M. The largest seller was Victory Capital Management, cutting an estimated $49.3M.
- 146 institutional investors held AngioDynamics (ANGO) as of Q2 2020, down from 158 in Q1 2020.
- Funds reported $374M of AngioDynamics stock for Q2 2020, down 14% quarter-over-quarter.
- 11 funds opened new AngioDynamics positions in Q2 2020 and 23 closed out, a net change of -12 holders.
- The largest AngioDynamics buyer in Q2 2020 was Millennium Management, an estimated $3.64M added.
- The largest AngioDynamics seller in Q2 2020 was Victory Capital Management, an estimated $49.3M sold.
Based on aggregated 13F filings for Q2 2020.